MCID: LCH002
MIFTS: 58

Lichen Planus

Categories: Genetic diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Lichen Planus

MalaCards integrated aliases for Lichen Planus:

Name: Lichen Planus 12 76 37 55 44 15 73
Lichen, Ruber Planus 12
Lichen Ruber Planus 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9201
ICD10 33 L43 L43.9
ICD9CM 35 697.0
MeSH 44 D008010
NCIt 50 C3189
SNOMED-CT 68 4776004
KEGG 37 H01654
UMLS 73 C0023646

Summaries for Lichen Planus

Disease Ontology : 12 A lichen disease that is located in skin, located in tongue or located in oral mucosa, which presents itself in the form of papules, lesions or rashes.

MalaCards based summary : Lichen Planus, also known as lichen, ruber planus, is related to lichen planus pemphigoides and lichen sclerosus, and has symptoms including pruritus An important gene associated with Lichen Planus is COL17A1 (Collagen Type XVII Alpha 1 Chain), and among its related pathways/superpathways are Akt Signaling and Allograft rejection. The drugs Triamcinolone and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include skin, tongue or and skin, and related phenotypes are Increased gamma-H2AX phosphorylation and digestive/alimentary

Wikipedia : 76 Lichen planus (LP) is a disease characterized by itchy reddish-purple polygon-shaped skin lesions on the... more...

Related Diseases for Lichen Planus

Diseases in the Lichen Planus family:

Lichen Planus, Familial Rare Lichen Planus

Diseases related to Lichen Planus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 381)
# Related Disease Score Top Affiliating Genes
1 lichen planus pemphigoides 34.7 COL17A1 DST
2 lichen sclerosus 31.3 COL17A1 GZMB TP53
3 dermatitis 31.0 FLG IFNG IL4 TLR9
4 pemphigus 31.0 COL17A1 DSG3 DST
5 graft-versus-host disease 31.0 GZMB IFNG TNF
6 viral infectious disease 30.9 IFNG IL4 MX1 TLR9 TNF
7 keratosis 30.9 FLG IVL KRT10
8 gingivitis 30.8 DEFB4A IL4 TNF
9 paraneoplastic pemphigus 30.8 COL17A1 DSG3 DST
10 erythema multiforme 30.6 CXCR3 GZMB ICAM1 IFNG TNF
11 periodontitis 30.6 IFNG IL4 TLR9 TNF
12 keratoacanthoma 30.4 FLG GZMB KRT10 KRT16 TP53
13 keratoconjunctivitis 30.4 ICAM1 IFNG IL4 TLR9 TNF
14 linear iga disease 30.4 COL17A1 DST
15 viral hepatitis 30.4 MX1 TLR9 TNF
16 bullous pemphigoid 30.4 COL17A1 DSG3 DST IVL
17 myasthenia gravis 30.3 IFNG IL4 TNF
18 keratoconjunctivitis sicca 30.3 IL4 TLR9 TNF
19 discoid lupus erythematosus 30.3 FLG GZMB IVL KRT10 KRT16
20 cutaneous lupus erythematosus 30.3 CXCR3 GZMB ICAM1 MX1 TNF
21 alopecia areata 30.3 CXCL9 GZMB ICAM1 IFNG TNF
22 conjunctivitis 30.3 ICAM1 IFNG IL4
23 pemphigoid gestationis 30.2 COL17A1 DST
24 acute graft versus host disease 30.1 GZMB IFNG IL4 TNF
25 human immunodeficiency virus infectious disease 30.1 IFNG TLR9 TNF
26 filariasis 30.1 IFNG TLR9 TNF
27 autoimmune disease 30.1 COL17A1 CXCR3 IFNG IL4 TLR9 TNF
28 rheumatoid arthritis 30.1 FLG ICAM1 IFNG IL4 ITGAL TNF
29 systemic lupus erythematosus 30.0 CXCR3 ICAM1 IFNG IL4 MX1 TLR9
30 papilloma 30.0 FLG IL4 IVL KRT10 KRT13 TP53
31 epidermolytic hyperkeratosis 29.9 FLG KRT10 KRT16
32 tinea corporis 29.9 DEFB4A KRT16
33 allergic contact dermatitis 29.8 CXCR3 FLG ICAM1 IFNG IL4 TNF
34 mycosis fungoides 29.8 CXCL9 CXCR3 GZMB ITGAL
35 contact dermatitis 29.7 CXCR3 FLG ICAM1 IFNG IL4 IVL
36 asthma 29.7 FLG ICAM1 IFNG IL4 TLR9 TNF
37 multiple sclerosis 29.6 CXCL9 CXCR3 ICAM1 IFNG IL4 MX1
38 basal cell carcinoma 29.6 IVL KRT10 KRT16 TP53
39 dermatitis, atopic 29.3 CXCL9 CXCR3 DEFB4A FLG ICAM1 IFNG
40 lichen disease 29.2 COL17A1 CXCL9 CXCR3 DST FLG ICAM1
41 psoriasis 29.0 CXCL9 CXCR3 DEFB4A FLG ICAM1 IFNG
42 actinic lichen planus 12.9
43 lichen planus pigmentosus 12.9
44 oral lichen planus 12.8
45 linear lichen planus 12.8
46 atrophic lichen planus 12.8
47 annular lichen planus 12.8
48 annular atrophic lichen planus 12.8
49 bullous lichen planus 12.6
50 rare lichen planus 12.5

Graphical network of the top 20 diseases related to Lichen Planus:



Diseases related to Lichen Planus

Symptoms & Phenotypes for Lichen Planus

UMLS symptoms related to Lichen Planus:


pruritus

GenomeRNAi Phenotypes related to Lichen Planus according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased gamma-H2AX phosphorylation GR00053-A 9.28 COL17A1 CXCL9 CXCR3 DEFB4A DSG3 IVL

MGI Mouse Phenotypes related to Lichen Planus:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.23 DSG3 ICAM1 IFNG IL4 KRT16 TLR9

Drugs & Therapeutics for Lichen Planus

Drugs for Lichen Planus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 147)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 124-94-7 31307
2
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
3 tannic acid Approved Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
4
Tacrolimus Approved, Investigational Phase 4,Phase 2,Not Applicable 104987-11-3 445643 439492
5
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 378-44-9 9782
6
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 137071-32-0 6447131 17753757
7
Apremilast Approved, Investigational Phase 4,Phase 2 608141-41-9 11561674
8
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
9
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 22916-47-8 4189
10
Chitosan Approved Phase 4 9012-76-4 71853
11
Glucosamine Approved, Investigational Phase 4 3416-24-8 439213
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
13
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
14
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2 302-25-0
15 Lycopene Approved, Investigational Phase 4,Phase 2 502-65-8 446925
16
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2 2921-57-5
17
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
18
Prednisolone hemisuccinate Experimental Phase 4,Phase 2 2920-86-7
19
Lactitol Investigational Phase 4 585-86-4 3871
20 Immunologic Factors Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
21 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
22 Triamcinolone hexacetonide Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
23 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
24 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
25 Hormones Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
27 triamcinolone acetonide Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
28 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
29 Triamcinolone diacetate Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable
30 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Early Phase 1
31 Antioxidants Phase 4,Phase 3,Phase 2,Phase 1
32 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Early Phase 1
33 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Antiemetics Phase 4,Phase 3,Phase 2,Early Phase 1
35 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
36 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
37 Calcineurin Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
38 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2
39 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
40 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Not Applicable
41 Betamethasone sodium phosphate Phase 4,Phase 3,Phase 2,Not Applicable
42 Dermatologic Agents Phase 4,Phase 2,Phase 3,Early Phase 1
43 Analgesics Phase 4,Phase 3,Phase 2
44 Antirheumatic Agents Phase 4,Phase 3,Phase 2
45 Betamethasone benzoate Phase 4,Phase 3,Phase 2,Not Applicable
46 Respiratory System Agents Phase 4,Phase 3,Phase 2,Not Applicable
47 Betamethasone Valerate Phase 4,Phase 3,Phase 2,Not Applicable 2152-44-5
48 Betamethasone-17,21-dipropionate Phase 4,Phase 3,Phase 2,Not Applicable
49 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
50 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 83)
# Name Status NCT ID Phase Drugs
1 Management of Pain in Oral Lichen Planus Completed NCT03572959 Phase 4 0.1 % topical triamcinolone acetonide
2 Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus Completed NCT02858297 Phase 4 Glucosamine sulfate;triamcinolone acetonide
3 A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus Completed NCT02587117 Phase 4 lycopene;Prednisolone
4 Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus Completed NCT02443311 Phase 4 Pimecrolimus 1% cream;Betamethasone 17-valerate 0.1% cream
5 Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia Recruiting NCT03422640 Phase 4 Apremilast
6 Pain Outcomes Following Intralesional Corticosteroid Injections Not yet recruiting NCT03630198 Phase 4 Corticosteroid with lidocaine;Corticosteroid with normal saline
7 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus Unknown status NCT01083420 Phase 3 Minocycline;Dexamethasone
8 Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT Unknown status NCT01282515 Phase 2, Phase 3 clobetasolpropionate;hexaminolevulinate
9 Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus Completed NCT02329600 Phase 3 green tea tablets (Green tea extract 5:1) 200 mg;Triamcinolone Acetonide
10 Efficacy of Elidel Cream on Erosive Oral Lichen Planus Completed NCT00130572 Phase 3 Pimecrolimus
11 Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus Completed NCT02421770 Phase 3
12 Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen Terminated NCT01061853 Phase 3 TOPICAL SIROLIMUS (RAPAMUNE*);TOPICAL BETAMETHASONE 0.05%
13 A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus Unknown status NCT01524744 Phase 2 Pimecrolimus ointment;Adcortyl
14 Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus Unknown status NCT01041625 Phase 2 Apremilast (CC-10004)
15 Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin Unknown status NCT01538732 Phase 2 alitretinoin
16 Treatmant of Oral Lichen Planus With Lycopene Completed NCT00656214 Phase 2 Lycopene;Placebo
17 Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus Completed NCT02453503 Phase 2 Licorice;Triamcinolone Acetonide
18 Efficacy of Purslane in Treatment of Oral Lichen Planus Completed NCT00746772 Phase 2 Purslane 235mg/day in one dosage;Placebo : one dosage
19 Pimecrolimus Cream for Oral Lichen Planus Completed NCT00297037 Phase 2 Pimecrolimus 1% cream
20 The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus Completed NCT02106468 Phase 2 Prednisone tablet 5mg;Omega-3 soft capsules 1000 mg
21 A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus Completed NCT00525421 Phase 2 Curcuminoids;Placebo
22 Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus Completed NCT02744378 Phase 2 Tacrolimus 0.1%;Clobetasol 0.05%
23 Cedar Honey in Oral Lichen Planus Completed NCT01974414 Phase 1, Phase 2 orally administered cedar honey
24 Dexamethasone to Treat Oral Lichen Planus Completed NCT00111072 Phase 2 dexamethasone 0.01% solution
25 Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus Completed NCT00102557 Phase 2 Hydroxychloroquine
26 Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other Completed NCT00484250 Phase 2 metronidazole,doxycycline
27 Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases Completed NCT02920658 Phase 2 NAVS Naphthalan;0.05% Betamethasone dipropionate
28 Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). Completed NCT01835587 Phase 1, Phase 2 CC-486
29 Dexamethasone Solution for the Treatment of Oral Lichen Planus Recruiting NCT02850601 Phase 2 Dexamethasone
30 Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus Recruiting NCT03026478 Phase 2 Betamethasone Dipropionate;Clobetasol Propionate
31 Topical INCB018424 Lichen Planus Recruiting NCT03697460 Phase 2 INCB018424
32 Intra-oral Treatment of OLP With Rivelin®-CLO Patches Recruiting NCT03592342 Phase 2 Clobetasol Propionate
33 Valchlor in the Treatment of Lichen Planopilaris Recruiting NCT03417141 Phase 2 Valchlor
34 Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus Active, not recruiting NCT03386643 Phase 2 Bifidobacterium animalis subsp. lactis HN019;Clobetasol propionate 0.05%
35 A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia Active, not recruiting NCT02538965 Phase 2 Lenalidomide
36 THE AP-GELP STUDY: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus Not yet recruiting NCT03656666 Phase 2 Apremilast;Placebo
37 Efficacy of Intralesional Injection of Platelet Rich Plasma in the Treatment of Patients With Erosive Oral Lichen Planus Not yet recruiting NCT03293368 Phase 2 Triamcinolone Acetonide
38 Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions. Not yet recruiting NCT03509675 Phase 2 Non-Steroidal Anti-inflammatory Topical Rinse;Placebos
39 A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus Terminated NCT00226174 Phase 2 Curcuminoids
40 Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream Terminated NCT00321750 Phase 2 1% pimecrolimus cream
41 A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus Terminated NCT00135733 Phase 2 Amevive (Alefacept);Placebo
42 Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus Terminated NCT00285779 Phase 2 Etanercept;Placebo
43 Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain Terminated NCT01584947 Phase 2 Bupivacaine;Placebo
44 Free Soft Tissue Graft in Treatment of Oral Lichen Planus Unknown status NCT00737854 Phase 1
45 Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus Unknown status NCT01375101 Phase 1 placebo;Quercetin
46 Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus Not yet recruiting NCT03793634 Phase 1 topical chamomile
47 Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus Unknown status NCT02532166 Not Applicable
48 Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus Unknown status NCT02276573 Not Applicable
49 Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study Unknown status NCT02332486 Not Applicable Qingxuan Decoction
50 The Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis Unknown status NCT02732145

Search NIH Clinical Center for Lichen Planus

Cochrane evidence based reviews: lichen planus

Genetic Tests for Lichen Planus

Anatomical Context for Lichen Planus

The Foundational Model of Anatomy Ontology organs/tissues related to Lichen Planus:

19
Skin, Tongue Or

MalaCards organs/tissues related to Lichen Planus:

41
Skin, T Cells, Tongue, Thyroid, Liver, Testes, B Cells

Publications for Lichen Planus

Articles related to Lichen Planus:

(show top 50) (show all 2219)
# Title Authors Year
1
Frontal Fibrosing Alopecia and Concomitant Lichen Planus Pigmentosus: A Case Series of Seven African American Women. ( 29601616 )
2018
2
Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial. ( 29909565 )
2018
3
Participation of the Th17 response in the pathogenesis of oral lichen planus. ( 29314294 )
2018
4
Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus. ( 29297958 )
2018
5
MicroRNA Microarray-Based Identification of Involvement of miR-155 and miR-19a in Development of Oral Lichen Planus (OLP) by Modulating Th1/Th2 Balance via Targeting eNOS and Toll-Like Receptor 2 (TLR2). ( 29813046 )
2018
6
Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: a meta-analysis study. ( 29731693 )
2018
7
Chronic graft versus host disease presenting as lichen planus pigmentosus. ( 29410549 )
2018
8
The association and potentially destructive role of Th9/IL-9 is synergistic with Th17 cells by elevating MMP9 production in local lesions of oral lichen planus. ( 29412487 )
2018
9
Hepatitis C screening in patients with oral lichen planus. ( 29971956 )
2018
10
Lichen planus pemphigoides. ( 29465781 )
2018
11
Bacillus Calmette-Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus. ( 29405515 )
2018
12
Vulvo-vaginal lichen planus: A focussed review for the clinician. ( 29961956 )
2018
13
Lichen planus pigmentosus inversus in children: Case report and updated review of the literature. ( 29231269 )
2018
14
A retrospective study of lichen planus pigmentosus with focus on palmoplantar involvement. ( 29947025 )
2018
15
Efficacy of photodynamic therapy in the treatment of symptomatic oral lichen planus: A systematic review. ( 29350426 )
2018
16
Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trial. ( 29947141 )
2018
17
Efficacy of photodynamic therapy and low level laser therapy against steroid therapy in the treatment of erosive-atrophic oral lichen planus. ( 29414735 )
2018
18
Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study. ( 29308937 )
2018
19
Beltlike lichen planus pigmentosus complicated with focal amyloidosis. ( 29894539 )
2018
20
Zosteriform Lichen Planus Pigmentosus Altering Segmental Vitiligo. ( 29911535 )
2018
21
Immunohistochemical Study of p53 Expression in Patients with Erosive and Non-Erosive Oral Lichen Planus. ( 29854885 )
2018
22
Linear bullous lichen planus associated with nivolumab. ( 29920744 )
2018
23
Comment on "Xerostomia and Salivary Gland Hypofunction in Patients with Oral Lichen Planus Before and After Treatment with Topical Corticosteroids". ( 29760823 )
2018
24
Oral lichen planus and HPV lesions. ( 29875955 )
2018
25
Rate of malignant transformation of oral lichen planus: A systematic review. ( 29738106 )
2018
26
Gastric parietal cell and thyroid autoantibodies in recurrent aphthous stomatitis patients with concomitant oral lichen planus. ( 29753458 )
2018
27
Expression and clinical significance of periostin in oral lichen planus. ( 29805541 )
2018
28
Evaluation of Combined Topical Ozone and Steroid Therapy in Management of Oral Lichen Planus. ( 29875865 )
2018
29
Lack of Association between Oral Lichen Planus and Hepatitis B and C Virus Infection - a Report from Southeast Iran ( 29936791 )
2018
30
Lichen planus pemphigoides. ( 29537153 )
2018
31
Blastomycosis-like Pyoderma Arising in Lichen Planus. ( 29462233 )
2018
32
Correlation Between Oral Lichen Planus and Thyroid Disease in China: A Case-Control Study. ( 29967591 )
2018
33
Dental Implants and Oral Lichen Planus. ( 29801195 )
2018
34
Alterations of Serum Lipid Profile Patterns in Oral Lichen Planus Patients: A Case-Control Study. ( 29962775 )
2018
35
An atypical clinical presentation of lichen planus pigmentosus with typical dermoscopic pattern. ( 29577239 )
2018
36
Time-resolved fluorescence spectroscopy for the diagnosis of oral lichen planus. ( 29436013 )
2018
37
Altered HMGB1 distribution in patients with lichen planus. ( 29888700 )
2018
38
LPS-induced Vitamin D Receptor Decrease in Oral Keratinocytes Is Associated With Oral Lichen Planus. ( 29335479 )
2018
39
Synchronous presentation of systemic lupus erythematosus and oral reticular lichen planus. ( 29387764 )
2018
40
Melanoma in situ mimicking a Lichen planus-like keratosis. ( 29350666 )
2018
41
Lichen planus: a rare cause of a narrowed esophagus. ( 29922754 )
2018
42
Association between TNFI+ - 308 G/A polymorphism and oral lichen planus (OLP): a meta-analysis. ( 29641751 )
2018
43
Dermoscopy of lichen planus pigmentosus in Indian patients - Pitfalls to avoid. ( 29620038 )
2018
44
Salivary proteomics in lichen planus: A relationship with pathogenesis? ( 29383810 )
2018
45
Association between hepatitis C infection in Thai patients with oral lichen planus: A case-control study. ( 29345111 )
2018
46
Hypertrophic Lichen Planus and Well-Differentiated Squamous Cell Carcinoma: A Diagnostic Conundrum. ( 29360655 )
2018
47
The importance of topical steroids after adhesiolysis in erosive lichen planus and graft versus host disease. ( 29884087 )
2018
48
Effectiveness of Oral Methotrexate Therapy versus Systemic Corticosteroid Therapy in Treatment of Generalised Lichen Planus. ( 29950252 )
2018
49
Detection of lichen planus pigmentosus with dermoscopy and reflectance confocal microscopy. ( 29790598 )
2018
50
Increased expression of p16 in both oral and genital lichen planus. ( 29924765 )
2018

Variations for Lichen Planus

Expression for Lichen Planus

Search GEO for disease gene expression data for Lichen Planus.

Pathways for Lichen Planus

Pathways related to Lichen Planus according to GeneCards Suite gene sharing:

(show all 37)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.36 CXCL9 CXCR3 IL4 ITGAL TLR9 TNF
2
Show member pathways
12.76 CXCL9 GZMB ICAM1 IFNG IL4 ITGAL
3
Show member pathways
12.55 ICAM1 IFNG IL4 MX1 TLR9 TNF
4 12.52 GZMB IFNG IL4 TLR9 TNF
5 12.37 ICAM1 ITGAL TNF TP53
6
Show member pathways
12.36 GZMB ICAM1 IFNG IL4 ITGAL TNF
7
Show member pathways
12.3 DSG3 FLG IVL KRT10 KRT13 KRT16
8
Show member pathways
12.29 DEFB4A IFNG IL4 TNF
9 12.25 ICAM1 ITGAL TNF TP53
10
Show member pathways
12.24 ICAM1 IFNG IL4 TNF TP53
11
Show member pathways
12.22 IFNG IL4 MX1 TNF TP53
12
Show member pathways
12.16 COL17A1 CXCL9 CXCR3 ICAM1 ITGAL TLR9
13 12.14 IFNG TLR9 TNF TP53
14
Show member pathways
12.05 DEFB4A IFNG IL4 TLR9 TNF
15 12.04 ICAM1 IFNG TNF TP53
16 11.92 IFNG IL4 ITGAL TNF
17 11.91 ICAM1 IL4 TNF TP53
18 11.78 ICAM1 IFNG ITGAL TNF
19 11.73 ICAM1 IFNG IL4 TNF TP53
20
Show member pathways
11.72 IFNG IL4 TNF
21 11.71 ICAM1 IFNG IL4 TP53
22 11.7 IFNG TLR9 TNF
23
Show member pathways
11.63 ICAM1 IFNG TNF
24 11.61 CXCL9 IFNG IL4 TNF
25
Show member pathways
11.6 GZMB IFNG TNF
26 11.56 ICAM1 ITGAL KRT10
27 11.52 IFNG TNF TP53
28 11.49 ICAM1 IL4 TNF
29 11.44 ICAM1 IFNG ITGAL
30 11.34 CXCL9 ICAM1 IFNG
31 11.28 CXCL9 CXCR3 ITGAL
32 11.26 CXCR3 GZMB IFNG IL4 TNF
33 11.25 IFNG IL4 TNF
34 11.17 IFNG IL4 TNF
35 11 ICAM1 IFNG TLR9 TNF
36 10.97 COL17A1 CXCL9 IL4 ITGAL TNF
37 10.71 ICAM1 IFNG ITGAL TLR9 TNF

GO Terms for Lichen Planus

Cellular components related to Lichen Planus according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.86 COL17A1 CXCL9 DEFB4A ICAM1 IFNG IL4
2 intermediate filament GO:0005882 9.35 DST FLG KRT10 KRT13 KRT16
3 hemidesmosome GO:0030056 9.16 COL17A1 DST
4 cornified envelope GO:0001533 8.92 DSG3 FLG IVL KRT10

Biological processes related to Lichen Planus according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.93 IFNG IL4 TLR9 TNF TP53
2 regulation of immune response GO:0050776 9.86 COL17A1 ICAM1 IL4 ITGAL
3 extracellular matrix organization GO:0030198 9.85 COL17A1 ICAM1 ITGAL TNF
4 defense response to virus GO:0051607 9.83 CXCL9 IFNG MX1 TLR9
5 defense response GO:0006952 9.76 CXCL9 DEFB4A MX1 TNF
6 keratinization GO:0031424 9.72 DSG3 IVL KRT10 KRT13 KRT16
7 peptide cross-linking GO:0018149 9.67 FLG IVL KRT10
8 positive regulation of nitric oxide biosynthetic process GO:0045429 9.65 ICAM1 IFNG TNF
9 inflammatory response GO:0006954 9.63 CXCL9 CXCR3 ITGAL KRT16 TLR9 TNF
10 hemidesmosome assembly GO:0031581 9.58 COL17A1 DST
11 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.57 TLR9 TNF
12 keratinocyte differentiation GO:0030216 9.56 FLG IVL KRT10 KRT16
13 positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996 9.51 ICAM1 TNF
14 immune response GO:0006955 9.5 CXCL9 CXCR3 DEFB4A IFNG IL4 TLR9
15 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.43 IFNG TNF
16 T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell GO:0002291 9.4 ICAM1 ITGAL
17 positive regulation of vitamin D biosynthetic process GO:0060557 9.37 IFNG TNF
18 cornification GO:0070268 9.1 DSG3 FLG IVL KRT10 KRT13 KRT16

Molecular functions related to Lichen Planus according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 CXCL9 IFNG IL4 TNF
2 structural molecule activity GO:0005198 9.1 DST FLG IVL KRT10 KRT13 KRT16

Sources for Lichen Planus

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....